Chapter - 8: References

exp date isn't null, but text field is

  1. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jan 12;393(10167):132. Erratum in: Lancet. 2019 Jun 22;393(10190):e44. PMID: 30496105; PMCID: PMC6227755.

  2. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population- Based Studies From 90 Countries. Circulation. 2016 Aug 9;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912. PMID: 27502908; PMCID: PMC4979614.

  3. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017 Jan 7;389(10064):37-55. doi: 10.1016/S0140- 6736(16)31919-5. Epub 2016 Nov 16. Erratum in: Lancet. 2020 Sep 26;396(10255):886. PMID: 27863813; PMCID: PMC5220163

  4. FACTSHEET 2022, Bangladesh. National Non communicable Disease Risk Factor Survey in Bangladesh according to WHO STEPS approach. Bangladesh College for Physicians and Surgeons (BCPS)

  5. Hanif AAM, Shamim AA, Hossain MM, Hasan M, Khan MSA, Hossaine M, Ullah MA, Sarker SK, Rahman SMM, Mitra DK, Mridha MK. Gender-specific prevalence and associated factors of hypertension among elderly Bangladeshi people: findings from a nationally representative cross-sectional survey. BMJ Open. 2021 Jan 21;11(1):e038326. doi: 10.1136/bmjopen-2020-038326. PMID: 33478960; PMCID: PMC7825269.

  6. Malik F, Al Mamun MA, M Ishraquzzaman, Kalimuddin M, Choudhury SR, et al. May Measurement Month (MMM) 2019: An Analysis of Blood Pressure Screening Results from Bangladesh. European Heart Journal Supplements (2021) 23 (Supplement B), B21– B23. doi:10.1093/eurheartj/suab017

  7. Khalequzzaman M, Chiang C, Choudhury SR, Yatsuya H, Al-Mamun MA, et al. Prevalence of non-communicable disease risk factors among poor shantytown residents in Dhaka, Bangladesh: a community-based cross-sectional survey. BMJ Open. 2017 Nov 14;7(11):e014710. doi: 10.1136/bmjopen-2016-014710. PMID: 29138190; PMCID: PMC5695399.

  8. Khanam MA, Lindeboom W, Koehlmoos TL, Alam DS, Niessen L, Milton AH. Hypertension: adherence to treatment in rural Bangladesh--findings from a population-based study. Glob Health Action. 2014 Oct 20;7:25028. doi: 10.3402/gha.v7.25028. PMID: 25361723; PMCID: PMC4212079.

  9. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020 Jun;38(6):982-1004. doi: 10.1097/HJH.0000000000002453. PMID: 32371787.

  10. Guideline for the pharmacological treatment of hypertension in adults. Geneva: World Health Organization; 2021. Available at: https://www.who.int/publications/i/item/9789240033986

  11. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. Erratum in: Eur Heart J. 2019 Feb 1;40(5):475. PMID: 30165516.

  12. Hypertension in adults: diagnosis and management. NICE guideline [NG136]. August 2019. Available at: https://www.nice.org.uk/guidance/ng136.

  13. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–e115. Available at: https://doi.org/10.1161/HYP.0000000000000065

  14. World Health Organization. Country Office for Bangladesh. (2013). National guidelines for management of hypertension in Bangladesh. World Health Organization. Country Office for Bangladesh. Available at: https://apps.who.int/iris/handle/10665/279486

  15. Sheppard, James P.; Lacy, Peter; Lewis, Philip S.; Martin, Una (2020). Measurement of blood pressure in the leg—a statement on behalf of the British and Irish Hypertension Society. Journal of Human Hypertensionhttps://doi.org/10.1038/s41371-020-0325-5; [accessed Jun 24 2023].

  16. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, 2017, Available at: www.cdc.gov/steadi

  17. HEARTS technical package for cardiovascular disease management in primary health care: risk based CVD management. Geneva: World Health Organization; 2020. Available at: https://www.who.int/publications/i/item/9789240001367 

  18. World Health Organization. (2020). WHO guidelines on physical activity and sedentary behaviour: at a glance. World Health Organization. https://apps.who.int/iris/handle/10665/337001 . License: CC BY-NC-SA 3.0 IGO

  19. Wei FF, Zhang ZY, Huang QF, Staessen JA. Diagnosis and management of resistant hypertension: state of the art. Nat Rev Nephrol. 2018 Jul;14(7):428-441. doi: 10.1038/s41581-018-0006-6. PMID: 29700488.

  20. Riaz BK, Islam MZ, Islam ANMS, et al. Risk factors for non-communicable diseases in Bangladesh: findings of the population based cross-sectional national survey 2018. BMJ Open. 2020;10:e041334. doi:10.1136/bmjopen-2020-041334

  21. Zaman MM. Choudhury SR. Ahmed J, Hossain SMA, Sobhan SMM, Turin TC. Prevalence of stroke in a rural population of Bangladesh. Global Heart 2014 Doi:10.1016/j.gheart.2014.04.007
  1. Mohammad QD, Habib M, Hogue A, Alam B, Hague B, Hossain 5, Rahman KM, Khan SU. Prevalence of storke above forty years Mymensingh Med J: 2011.20 640-44

  2. Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, Hemphill JC 3rd, Johnson R, Keigher KM, Mack WJ, Mocco J, Newton EJ, Ruff IM, Sansing LH, Schulman S, Selim MH, Sheth KN, Sprigg N, Sunnerhagen KS; American Heart Association/American Stroke Association. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022 Jul;53(7):e282-e361. doi: 10.1161/STR.0000000000000407. Epub 2022 May 17. PMID: 35579034.

 

  1. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24. Erratum in: Stroke. 2021 Jul;52(7):e483- e484. PMID: 34024117.

  2. Gorelick PB, Whelton PK, Sorond F, Carey RM. Blood Pressure Management in Stroke. Hypertension. 2020 Dec;76(6):1688-1695. doi: 10.1161/HYPERTENSIONAHA.120.14653. Epub 2020 Oct 12. PMID: 33040620; PMCID: PMC7666043.

  3. Jain AR, Bellolio MF, Stead LG. Treatment of hypertension in acute ischemic stroke. Curr Treat Options Neurol. 2009 Mar;11(2):120-5. doi: 10.1007/s11940-009-0015-7. PMID: 19210914.

  4. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, et. al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-e418. doi: 10.1161/STR.0000000000000211. Epub 2019 Oct 30. Erratum in: Stroke. 2019 Dec;50(12):e440-e441. PMID: 31662037.

  5. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1-7. doi:1016/j.ejogrb.2013.05.005

  6. Prevalence of pregnancy induced hypertension in Bangladesh. NIPORT 2021

  7. World Health Organization, United Nations Population Fund, World Bank & United Nations Children's Fund (UNICEF). (2015). Pregnancy, childbirth, postpartum and newborn care: a guide for essential practice, 3rd ed.. World Health Organization. https://apps.who.int/iris/handle/10665/249580  

  8. World Health Organization. Life Saving Skills Manual, Essential Obstetric and Newborn Care, Royal College of Obstreticians and Gynaecologists. 2007

  9. Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, et al; on behalf of the American Diabetes Association, Summary of Revisions: Standards of Care in Diabetes—2023. Diabetes Care 1 January 2023; 46 (Supplement_1): S5–S9. https://doi.org/10.2337/dc23-Srev

  10. Kidney Foundation Bangladesh, Newsletter 4 issue; July 2022

  11. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1–S87

  12. Dand SJ. Treating hypertension in acute ischemic stroke: from the stroke prevention and atherosclerosis research centre: University of Western Ontario, London. Circulation: 2008;118: 176-87

  13. SPRINT Research Group; Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9. Erratum in: N Engl J Med. 2017 Dec 21;377(25):2506. PMID: 26551272; PMCID: PMC4689591.

  14. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 39:S1-S266, 2002 (Suppl 1). Available at: kdoqi.org

  15. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957–967.

  16. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A. Effects of intensive blood pressure lowering on cardiovascular and renal outcome updated systematic review and meta-analysis. Lancet 2016;387:435–443.

  17. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, Whit IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 2014;383:1899–1911

  18. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering treatment. Prevention of heart failure and new-onset heart failure–meta-analyses of randomized trials. J Hypertens 2016;34:373–384.

  19. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlof B. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004;292:2350–2356.

  20. Soliman EZ, Byington RP, Bigger JT, Evans G, Okin PM, Goff DC Jr, Chen H. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with diabetes mellitus: action to control cardiovascular risk in diabetes blood pressure trial. Hypertension 2015;66:1123–1129.

  21. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129–2200 

  22. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993–1004

  23. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298(8):874–879

  24. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and prehypertension among adolescents. J Pediatr. 2007;150(6):640–644

  25. Islam MR, Islam LT, Haque SS, Jubayer M, Mollah AH, Ahmed SM, et al. Hypertension in School Children of Dhaka City and Associated Risk Factors. Mymensingh Med J. 2019 Oct;28(4):849-853. PMID: 31599250.

  26. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2,suppl 4th Report):555–576

  27. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017 Sep;140(3):e20171904. doi: 10.1542/peds.2017-1904. Epub 2017 Aug 21. Erratum in: Pediatrics. 2017 Nov 30; Erratum in: Pediatrics. 2018 Sep;142(3): PMID: 28827377.

  28. Dionne, J. Updated guideline may improve the recognition and diagnosis of hypertension in children and adolescents; review of the 2017 AAP blood pressure clinical practice guideline. Current Hypertension Reports. 2017. vol 19 (10), p84.

  29. Prasetyo RV et al. Treatment of Hypertension. In: Pediatric Nephrology On- The- Go, Fourth Edition. Editors Hui Kim Yap, Sharon Teo Kar-Hui Ng. World Scientific Publishing Co Pte. p 109-140.

  30. Mayer-Davis EJ, Ma B, Lawson A, et al; SEARCH for Diabetes in Youth Study Group. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2009;7 (2):89–95.

  31. Stern MP. Diabetes and cardiovascular disease. The “common soil” hypothesis. Diabetes. 1995;44 (4):369–374.

  32. Martino F, Puddu PE, Pannarale G, et al. Hypertension in children and adolescents attending a lipid clinic. Eur J Pediatr. 2013;172 (12):1573–1579.

  33. Marcus CL, Brooks LJ, Draper KA, et al; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3). Available at: www.pediatrics.org/cgi/ content/full/130/3/e714.

  34. Rawal L, Jubayer S, Choudhury SR, Islam SMS, Abdullah AS. Community health workers for non-communicable diseases prevention and control in Bangladesh: a qualitative study. Glob Health Res Policy. 2020 Dec 24;6(1):1. doi: 10.1186/s41256-020-00182-z. PMID: 33407942; PMCID: PMC7786185.

  35. Abdullah AS, et al. Use of community health workers to manage and prevent noncommunicable diseases: policy options based on the findings of the COACH study. Delhi: World Health Organization; 2019.

  36. Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, Turner EL, Morisky D, Kasturiratne A, Khan AH, Clemens JD, Ebrahim S, Assam PN, Feng L; COBRA-BPS Study Group. A Community-Based Intervention for Managing Hypertension in Rural South Asia. N Engl J Med. 2020 Feb 20;382(8):717-726. doi: 10.1056/NEJMoa1911965. PMID: 32074419.

  37. Islam MA, et al. Cost-effectiveness of community health workers in tuberculosis control in Bangladesh. Bull World Health Organ. 2002;80(6):445–450. [PMC free article] [PubMed] [Google Scholar]

  38. Mishra SR, et al. Mitigation of non-communicable diseases in developing countries with community health workers. Glob Health. 2015;11(1):43. doi: 10.1186/s12992-015-0129- 5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]